Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

Rise of
+0.95 (+1.00%) Amgen Inc. - [Ticker: AMGN]Chart Amgen Inc.  News Amgen Inc.  Download Historical Prices for Metastock Amgen Inc. and Others  Technical Analysis Amgen Inc.  
Last Trade202.37Last Trade Time2018-11-29 - 00:00:00
Variation+0.95 (+1.00%)Open199.78
Volume1,836,703Average Volume (3m)0
YieldBid / Ask175.89 x 300 - 175.99 x 200
Former Close201.4252 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Amgen Inc. -  [Ticker: AMGN] chart
Change to Amgen Inc. Interactive Technical Analysis Chart

Last 10 Forum Topics about Amgen Inc.:
No topics about Amgen Inc. [AMGN] have been found, but a search on the Forum for more topics related to Amgen Inc. is advised.

 News about Amgen Inc. [AMGN]:   (ordered by relevance)
  1. Amgen Inc. (NASDAQ:AMGN) is favoured by institutional owners who hold 77% of the company  Simply Wall St
  2. Amgen Inc. stock outperforms market on strong trading day  MarketWatch
  3. What is the Market's View on Amgen, Inc. (AMGN) Stock's Price and Volume Trends Wednesday?  InvestorsObserver
  4. Amgen Inc. (AMGN): Are the Stars Lining Up for Investors?  The InvestChronicle
  5. Purchase Of Shares In Amgen Inc. (AMGN) By SUGAR RONALD D  The Fosters Leader
Amgen (AMGN) Boosts Outlook Despite Pricing Pressure for Some Drugs  Bloomberg Amgen's (AMGN) KRAS Inhibitor Gets CHMP Nod for Lung Cancer  Entrepreneur Amgen Inc. could expand New Albany manufacturing plant - Columbus Business First  Columbus Business First Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region  PRNewswire Glioblastoma Multiforme Treatment Market to grow by USD 1.41 billion | Evolving Opportunities with Amgen Inc. & Amneal Pharmaceuticals Inc. | 17000+ Technavio Reports  Yahoo Finance Bristol-Myers Squibb: Deucravacitinib Applications Advance in U.S., Europe  MarketWatch Amgen To Present At The 2021 Piper Sandler Healthcare Conference  Yahoo Finance Amgen To Present At The 2021 Evercore ISI Healthcare Conference  Yahoo Finance Is Amgen (NASDAQ:AMGN) A Risky Investment?  Nasdaq Amgen Q3 non-GAAP net income rises 8% YoY driven by 4% increase in revenues  Seeking Alpha 3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale  Motley Fool The Zacks Analyst Blog Highlights: Disney, Amgen, Booking Holdings, General Motors, and BCE  Entrepreneur Analyst Ratings For Amgen - Benzinga  Benzinga Global Autoinjectors Markets Report 2021-2026: Growing Prevalence of Targeted Therapies, Rising Incidence of Anaphylaxis, and Increasing Number of Regulatory Approvals -  Business Wire Global Antibody Drugs Market (2021 to 2026) - Featuring Abbvie, Amgen and Biogen Among Others -  Yahoo Finance Bone Degeneration Therapeutics Market Growth in Future Scope 2021-2028 | Amgen, Inc., Fate Therapeutics, Inc., Bone Therapeutics SA, Juventus Therapeutics, Inc.  Medgadget Preimplantation Genetic Diagnosis Market to Garner US$ 81.6 Million by 2028 | Amgen, Quest Diagnostics, Genentech Inc., Vertex  Medgadget Aptose to Hold Corporate Update Monday, December 13th  Investing News Network Jasper Therapeutics: Advancing Cures With HSC Transplants And Safer Prior Conditioning  Seeking Alpha Ligand's (LGND) Drug-Developing Technologies Holds Potential  Nasdaq Moderna Inc. stock underperforms Tuesday when compared to competitors  MarketWatch AstraZeneca PLC ADR underperforms Wednesday when compared to competitors  MarketWatch Amgen profit, sales fall on lower drug prices; shares drop 3.4%  Reuters Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases  PRNewswire Theranos trial: Prosecutors rest case against Elizabeth Holmes 56% of Millennials Got a Side Hustle During the Pandemic. Should You?  Nasdaq US open: Stocks trade higher following Powell's reappointment | Financial News  London South East Amgen Stock Set To Rise After Lumakras Approval  Forbes These Promising Clinical Results Could Be Huge for Amgen Investors  Motley Fool Amgen: Collateral Damage  Seeking Alpha Amgen Inc. (AMGN) Presents At Cantor Global Healthcare 2021 Conference (Transcript)  Seeking Alpha Lung cancer patients in England to receive Amgen drug that targets a gene mutation  Reuters The global pharmaceutical drug delivery market is projected to reach USD 2,206.5 billion by 2026 from USD 1,656.9 billion in 2021, at a CAGR of 5.9%  Yahoo Finance UK Amgen v. Sanofi: Who Decides Full Scope Enablement  Patently-O Fitch Rates Amgen's Senior Unsecured Notes 'BBB+'; Outlook Stable  Fitch Ratings Amgen Inc. (AMGN) CEO Bob Bradway Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)  Seeking Alpha Amgen, Inc. (AMGN) on Inflammation Portfolio from EADV (Transcript)  Seeking Alpha Intel, Amgen Inc. share losses contribute to Dow's nearly 100-point fall  MarketWatch Amgen Inc.'s (AMGN) Management Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)  Seeking Alpha Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 70% Return On Equity?  Nasdaq What Type Of Shareholders Make Up Amgen Inc.'s (NASDAQ:AMGN) Share Registry?  Simply Wall St Amgen Avoids Supreme Court Review of Patents on Enbrel Drug  Bloomberg Biotech ETFs  Motley Fool Read This Before Considering Amgen Inc. (NASDAQ:AMGN) For Its Upcoming US$1.76 Dividend  Simply Wall St The Dogs of the Dow Are Ending the Year With a Whimper  Barron's Should You Buy Amgen Stock At $225?  Forbes Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst  FiercePharma Amgen Inc.'s (NASDAQ:AMGN) Intrinsic Value Is Potentially 57% Above Its Share Price  Simply Wall St Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 16, 2021  Nasdaq Amgen Boosts Cancer Drive With $1.9 Billion Five Prime Deal  Bloomberg Is Amgen (NASDAQ:AMGN) Using Too Much Debt?  Simply Wall St Analyst Rating: Will Amgen, Inc. (AMGN) Stock Outperform the Market?  InvestorsObserver Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2021  Nasdaq Amgen Reports Fourth Quarter And Full Year 2020 Financial Results  PRNewswire Amgen blocks Sandoz, Zydus generics of psoriasis drug Otezla until 2028  Reuters Global Autoinjectors Markets Report 2021-2026: Growing Prevalence of Targeted Therapies, Rising Incidence  Benzinga Amgen to Acquire Rodeo Therapeutics Corporation  PRNewswire BioAge Signs Exclusive Agreement With Amgen To Develop and Commercialize Amgen's Phase 1 APJ Agonist To Treat Diseases of Aging  Business Wire What do the Fundamentals Predict for Amgen, Inc. (AMGN) Stock?  InvestorsObserver Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments  PRNewswire Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for  Nasdaq Amgen Successfully Completes Acquisition Of Teneobio, Inc.  PRNewswire Amgen Inc To Acquire Five Prime Therapeutics - Shares Rally  AskTraders Amgen Becomes Oversold  Forbes Amgen Inc. stock falls Friday, underperforms market  MarketWatch Amgen : Named One of the ?World's Best Workplaces' Dow jumps 275 points on gains in IBM, Amgen Inc. stocks  MarketWatch Amgen's Psoriasis Drug Patents Are Valid, NJ Court Told  Law360 Generic Drugs Market witnesses Emergence of Amgen Inc. and Dr. Reddys Laboratories Ltd. as Key Market Contributors| 17000 + Technavio  Yahoo Finance Global Gene Therapy Market Size 2021-2028, Share, Growth  GlobeNewswire Amgen Inc. stock falls Thursday, underperforms market  MarketWatch Delek (DK) Stock Declines 6.1% Despite Beating on Q3 Earnings  Nasdaq Amgen taps Holly Springs for $380M investment, hundreds of jobs - Triangle Business Journal  Triangle Business Journal Amgen Inc. v. Sanofi (Fed. Cir. 2021) | McDonnell Boehnen Hulbert & Berghoff LLP - JDSupra  JD Supra Merck and Amgen Stocks Fall on Morgan Stanley Downgrades  TheStreet 1Q21 Earnings Reveal Plenty Of Upside In Amgen, McDonald?s And Colgate-Palmolive  Forbes Amgen Inc. stock falls Monday, still outperforms market  MarketWatch ESMO: With Mirati hot on its tail, Amgen's KRAS-targeting Lumakras combo heads into late-stage colorectal cancer testing  FiercePharma Amgen Successfully Completes Acquisition Of Five Prime Therapeutics  PRNewswire Amgen: A Defensive Play In An Expensive Market  Seeking Alpha Amgen Denied Petition To Rehear Enablement Requirements For Biotech Patents  JD Supra ASCO: Amgen's stomach cancer drug, nabbed in Five Prime buyout, extends patients' lives in phase 2  FierceBiotech Kyowa Kirin, Amgen ink blockbuster deal for potential atopic dermatitis treatment  BioWorld Online Amgen's latest Lumakras data in KRAS cancer underscore the bumpy road for combo strategy: analyst  FiercePharma Amgen Inc. stock rises Wednesday, outperforms market  MarketWatch Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies Celiac Diseases Drugs Market Report Featuring Major Vendors including Amgen Inc., AMYRA Biotech AG & BioLineRx Ltd. | Discover Company Insights in Technavio  Yahoo Finance Is Amgen (AMGN) a Good Choice for Dow Membership?  Investopedia Is Amgen's Acquisition of Five Prime a Good Move for the Big Biotech?  Motley Fool Amgen (AMGN) Repatha Gets FDA Nod for Expanded Use in Kids  Entrepreneur Amgen-Backed Biotech Firm Hummingbird Said to Weigh US IPO  Bloomberg Amgen's $2 billion bid for Five Prime outlasted 15 potential partners - San Francisco Business Times  San Francisco Business Times IN BRIEF: Amgen sues Aurobindo over proposed generic for dialysis patients  Reuters Did You Participate In Any Of Amgen's (NASDAQ:AMGN) Respectable 81% Return?  Simply Wall St Amgen to Acquire TeneoBio  Sovereign Wealth Fund Institute Amgen Inc. stock outperforms competitors despite losses on the day  MarketWatch Amgen Enters Oversold Territory  Nasdaq Amgen's up-and-coming KRAS inhibitor gets a name: Lumakras  FierceBiotech Amgen, The Lundquist Institute Announce That Diadem Therapeuctics Will Receive The First Amgen Golden Ticket To BioLabs LA  Benzinga
For more news about Amgen Inc. click here:
Amgen Inc. News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources